SQZ Trademark

Trademark Overview


On Monday, October 26, 2020, a trademark application was filed for SQZ with the United States Patent and Trademark Office. The USPTO has given the SQZ trademark a serial number of 90279294. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, July 10, 2024. This trademark is owned by SQZ BIOTECHNOLOGIES COMPANY. The SQZ trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals for the treatment of medical conditions, namely, for modifying the immune response to treat cancer, autoimmune diseases, infectious diseases, and regenerative diseases for medical purposes, for modifying cells to treat rare diseases, cancer, autoimmune diseases, infectious diseases, and regenerative diseases for medical purposes; cells for medical use, namely, cells for use in creating cell and gene therapies for the treatment of medical conditions

Cell and gene therapies for the treatment of medical conditions for medical purposes, namely, cancer, rare diseases, autoimmune diseases, regenerative diseases and infectious diseases
sqz

General Information


Serial Number90279294
Word MarkSQZ
Filing DateMonday, October 26, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, July 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 16, 2021

Trademark Statements


Goods and ServicesPharmaceuticals for the treatment of medical conditions, namely, for modifying the immune response to treat cancer, autoimmune diseases, infectious diseases, and regenerative diseases for medical purposes, for modifying cells to treat rare diseases, cancer, autoimmune diseases, infectious diseases, and regenerative diseases for medical purposes; cells for medical use, namely, cells for use in creating cell and gene therapies for the treatment of medical conditions
Goods and ServicesCell and gene therapies for the treatment of medical conditions for medical purposes, namely, cancer, rare diseases, autoimmune diseases, regenerative diseases and infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 16, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 16, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSTEMCELL TECHNOLOGIES CANADA INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressVANCOUVER, BC V6A1B6
CA

Party NameSQZ BIOTECHNOLOGIES COMPANY
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Party NameSQZ BIOTECHNOLOGIES COMPANY
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events


Event DateEvent Description
Thursday, October 29, 2020NEW APPLICATION ENTERED
Tuesday, March 30, 2021NON-FINAL ACTION WRITTEN
Wednesday, December 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 25, 2021ASSIGNED TO EXAMINER
Tuesday, April 13, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 30, 2021NON-FINAL ACTION E-MAILED
Tuesday, March 30, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 13, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 13, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 30, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 6, 2021ASSIGNED TO LIE
Thursday, October 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 11, 2023SOU EXTENSION 2 FILED
Tuesday, January 11, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 11, 2022SOU TEAS EXTENSION RECEIVED
Monday, July 11, 2022SOU EXTENSION 1 FILED
Monday, July 11, 2022SOU EXTENSION 1 GRANTED
Wednesday, July 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 11, 2023SOU EXTENSION 2 GRANTED
Monday, July 10, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 10, 2023SOU EXTENSION 3 FILED
Monday, July 10, 2023SOU EXTENSION 3 GRANTED
Wednesday, July 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 3, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 16, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, January 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 3, 2024SOU EXTENSION 4 FILED
Wednesday, January 3, 2024SOU EXTENSION 4 GRANTED
Friday, January 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 10, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2024SOU EXTENSION 5 FILED
Wednesday, July 10, 2024SOU EXTENSION 5 GRANTED
Monday, July 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED